Literature DB >> 9520222

Distributed cognition and knowledge-based controlled medical terminologies.

J J Cimino1.   

Abstract

Controlled medical terminologies (CMTs) are playing central roles in clinical information systems and medical knowledge resource applications. As these terminologies grow, they are able to support more complex tasks but require more intensive efforts to create and maintain them. Several terminologies are evolving into knowledge bases of medical concepts. The knowledge they include is being used to support distributed cognition in two forms: complex medical decisions involving multiple people and applications, and coordination of maintenance of the terminologies themselves.

Entities:  

Mesh:

Year:  1998        PMID: 9520222     DOI: 10.1016/s0933-3657(97)00048-1

Source DB:  PubMed          Journal:  Artif Intell Med        ISSN: 0933-3657            Impact factor:   5.326


  5 in total

1.  Terminology Query Language: a server interface for concept-oriented terminology systems.

Authors:  M A Hogarth; M Gertz; F A Gorin
Journal:  Proc AMIA Symp       Date:  2000

Review 2.  Interface terminologies: facilitating direct entry of clinical data into electronic health record systems.

Authors:  S Trent Rosenbloom; Randolph A Miller; Kevin B Johnson; Peter L Elkin; Steven H Brown
Journal:  J Am Med Inform Assoc       Date:  2006-02-24       Impact factor: 4.497

Review 3.  A review of auditing methods applied to the content of controlled biomedical terminologies.

Authors:  Xinxin Zhu; Jung-Wei Fan; David M Baorto; Chunhua Weng; James J Cimino
Journal:  J Biomed Inform       Date:  2009-03-12       Impact factor: 6.317

4.  Barriers to the clinical implementation of compositionality.

Authors:  L K McKnight; P L Elkin; P V Ogren; C G Chute
Journal:  Proc AMIA Symp       Date:  1999

5.  Common data model for neuroscience data and data model exchange.

Authors:  D Gardner; K H Knuth; M Abato; S M Erde; T White; R DeBellis; E P Gardner
Journal:  J Am Med Inform Assoc       Date:  2001 Jan-Feb       Impact factor: 4.497

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.